BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12634416)

  • 21. Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts.
    Li H; Abou el-Ezz AY; Gambrell BE; Ildstad ST
    Transplantation; 1995 Jul; 60(1):59-65. PubMed ID: 7624944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microchimerism and tolerance after in utero bone marrow transplantation in mice.
    Kim HB; Shaaban AF; Yang EY; Liechty KW; Flake AW
    J Surg Res; 1998 Jun; 77(1):1-5. PubMed ID: 9698523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chimerism on the mice heart transplanted survival with the bone marrow infusion.
    Jiang H; Tu H; Chen Z; Chen R; Wang Y; Wang M; Jin J; Feng S; Chen W; Bi Y; Wang H; Mao Y; Shou Z; Chen J
    Transpl Immunol; 2011 Dec; 25(4):202-6. PubMed ID: 21911062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
    Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
    Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers.
    van Pel M; van Breugel DW; Vos W; Ploemacher RE; Boog CJ
    Bone Marrow Transplant; 2003 Jul; 32(1):15-22. PubMed ID: 12815473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
    Gorantla VS; Prabhune KA; Perez-Abadia G; Ildstad ST; Maldonado C; Orhun HI; Majzoub RK; Francois CG; Kakoulidis TP; Brouha PC; Anderson GL; Pidwell DJ; Breidenbach WC; Barker JH
    Transplantation; 2003 Apr; 75(7):922-32. PubMed ID: 12698075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kwon CH; Noh JH; Kim SJ
    Immunol Lett; 2006 Feb; 102(2):215-21. PubMed ID: 16260045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts.
    Chen J; He Q; Xu H; Su L; Zhang J; Xiong S
    Transpl Immunol; 2004 Dec; 13(4):283-8. PubMed ID: 15589741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
    Koh CY; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
    Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
    Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
    Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ
    Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice.
    Exner BG; Que X; Mueller YM; Domenick MA; Neipp M; Ildstad ST
    Surgery; 1999 Aug; 126(2):121-6. PubMed ID: 10455873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.